Larvol Delta - Cognition-Therapeutics-receives-758-million-NIA-grant-for-540patient-phase-2-study-of-CT1812-in-collaboration-with-the-Alzheimer39s-Clinical-Trials-Consortium

Elayta (CT1812) - Cognition Therap

http://www.globenewswire.com/news-release/2020/06/08/2044902/0/en/Cognition-Therapeutics-Receives-75-8-Million-NIA-Grant-for-540-Patient-Phase-2-Study-of-CT1812-in-Collaboration-with-the-Alzheimer-s-Clinical-Trials-Consortium.html

Jun 8, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next